- Home
- STRO vs ZENV Comparison
STRO vs ZENV Comparison
Compare STRO & ZENV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STRO
- ZENV
- Stock Information
- Founded
- STRO 2003
- ZENV 2005
- Country
- STRO United States
- ZENV Brazil
- Employees
- STRO 306
- ZENV N/A
- Industry
- STRO Biotechnology: Biological Products (No Diagnostic Substances)
- ZENV Computer Software: Prepackaged Software
- Sector
- STRO Health Care
- ZENV Technology
- Exchange
- STRO Nasdaq
- ZENV Nasdaq
- Market Cap
- STRO 165.7M
- ZENV 146.3M
- IPO Year
- STRO 2018
- ZENV 2021
- Fundamental
- Price
- STRO $2.01
- ZENV $2.33
- Analyst Decision
- STRO Strong Buy
- ZENV
- Analyst Count
- STRO 7
- ZENV 0
- Target Price
- STRO $12.14
- ZENV N/A
- AVG Volume (30 Days)
- STRO 984.3K
- ZENV 162.5K
- Earning Date
- STRO 11-13-2024
- ZENV 11-18-2024
- Dividend Yield
- STRO N/A
- ZENV N/A
- EPS Growth
- STRO N/A
- ZENV N/A
- EPS
- STRO N/A
- ZENV N/A
- Revenue
- STRO $160,955,000.00
- ZENV $173,594,726.00
- Revenue This Year
- STRO N/A
- ZENV $25.56
- Revenue Next Year
- STRO N/A
- ZENV $6.02
- P/E Ratio
- STRO N/A
- ZENV N/A
- Revenue Growth
- STRO 230.90
- ZENV 23.49
- 52 Week Low
- STRO $1.67
- ZENV $1.00
- 52 Week High
- STRO $6.13
- ZENV $3.88
- Technical
- Relative Strength Index (RSI)
- STRO 46.47
- ZENV 54.30
- Support Level
- STRO $1.72
- ZENV $2.29
- Resistance Level
- STRO $2.15
- ZENV $2.77
- Average True Range (ATR)
- STRO 0.14
- ZENV 0.32
- MACD
- STRO 0.05
- ZENV -0.02
- Stochastic Oscillator
- STRO 70.83
- ZENV 36.94
About STRO Sutro Biopharma Inc.
Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers.
About ZENV Zenvia Inc.
Zenvia Inc provides a platform that enables companies to create unique journeys for their end customers across a variety of channels. The company operates in two reportable segments namely CPaaS and SaaS. It has a geographic presence in Brazil, the USA, Argentina, Mexico, and Others. The company generates the majority of its revenue from Brazil.